Guix, FX;
Sannerud, R;
Berditchevski, F;
Arranz, AM;
Horre, K;
Snellinx, A;
Thathiah, A;
... De Strooper, B; + view all
(2017)
Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments.
Molecular Neurodegeneration
, 12
, Article 25. 10.1186/s13024-017-0165-0.
Preview |
Text
De Strooper_art%253A10.1186%252Fs13024-017-0165-0.pdf - Published Version Download (8MB) | Preview |
Abstract
BACKGROUND: The mechanisms behind Aβ-peptide accumulation in non-familial Alzheimer’s disease (AD) remain elusive. Proteins of the tetraspanin family modulate Aβ production by interacting to γ-secretase. METHODS: We searched for tetraspanins with altered expression in AD brains. The function of the selected tetraspanin was studied in vitro and the physiological relevance of our findings was confirmed in vivo. RESULTS: Tetraspanin-6 (TSPAN6) is increased in AD brains and overexpression in cells exerts paradoxical effects on Amyloid Precursor Protein (APP) metabolism, increasing APP-C-terminal fragments (APP-CTF) and Aβ levels at the same time. TSPAN6 affects autophagosome-lysosomal fusion slowing down the degradation of APP-CTF. TSPAN6 recruits also the cytosolic, exosome-forming adaptor syntenin which increases secretion of exosomes that contain APP-CTF. CONCLUSIONS: TSPAN6 is a key player in the bifurcation between lysosomal-dependent degradation and exosome mediated secretion of APP-CTF. This corroborates the central role of the autophagosomal/lysosomal pathway in APP metabolism and shows that TSPAN6 is a crucial player in APP-CTF turnover.
Type: | Article |
---|---|
Title: | Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1186/s13024-017-0165-0 |
Publisher version: | http://doi.org/10.1186/s13024-017-0165-0 |
Language: | English |
Additional information: | © The Author(s). 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Keywords: | Science & Technology, Life Sciences & Biomedicine, Neurosciences, Neurosciences & Neurology, Alzheimer's disease, Amyloid precursor protein, Intraluminal vesicles, Multivesicular bodies, Tetraspanin-6, FAMILIAL ALZHEIMERS-DISEASE, GAMMA-SECRETASE, ENRICHED MICRODOMAINS, BETA-SECRETASE, MOUSE MODELS, INHIBITION, SYNTENIN, APP, PROTEOLYSIS, DYSFUNCTION |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UK Dementia Research Institute HQ |
URI: | https://discovery.ucl.ac.uk/id/eprint/1550078 |
Archive Staff Only
View Item |